Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

Nicola Polverelli , Katya Mauff , Nicolaus Kröger , Marie Robin , Dietrich Beelen , David Beauvais (1) , Patrice Chevallier , Mohamad Mohty , Jakob Passweg , Marie Thérèse Rubio , Johan Maertens , Jürgen Finke , Martin Bornhäuser , Radovan Vrhovac , Grzegorz Helbig , Jean‐baptiste Mear , Luca Castagna (2, 3) , Péter Reményi , Emanuele Angelucci , Dimitrios Karakasis , Jose Rifòn , Tiarlan Sirait , Domenico Russo , Liesbeth Wreede , Tomasz Czerw , Juan Carlos Hernández‐boluda , Patrick Hayden , Donal Mclornan , Ibrahim Yakoub‐agha (4)

1 PRISM - Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192
2 Service d’Hématologie [Institut Paoli Calmettes, Marseille]
3 CRCM - Centre de Recherche en Cancérologie de Marseille
4 INFINITE (Ex-Liric) - Institute for Translational Research in Inflammation - U 1286

Domaines: Cancer; Immunologie

Nicola Polverelli, Katya Mauff, Nicolaus Kröger, Marie Robin, Dietrich Beelen, et al.. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT). American Journal of Hematology, 2021, 96 (1), pp.69-79. ⟨10.1002/ajh.26020⟩. ⟨hal-03623698⟩